Disease processes that produce ischaemia are a common cause of morbidi
ty and mortality in companion animals. The majority of damage to trans
iently ischaemia tissues occurs following reperfusion and not during i
schaemia per se. This discovery raises the encouraging prospect that t
herapeutic intervention prior to reperfusion may reduce the severity o
f ischaemic damage. Recently, the central role of oxygen-derived free
radicals (oxyradicals) in reperfusion injury has been demonstrated. It
appears that the adverse consequences of ischaemic diseases can be re
duced by optimizing the anti-oxidant capability of tissues with anti-o
xidant nutrients or drugs. The importance of oxyradicals in individual
ischaemic diseases of the dog and cat, however, remains largely uninv
estigated. Similarly, the best pharmaceutical and nutritional approach
es to the therapy of oxyradical-mediated damage have yet to be devised
.